ஸ் சிஇஆர்டிஐஎஃப்ஐசிஏடிஐஓஎன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Axio Biosolutions receives CE Certification for next gen wound-care product MaxioCel
Axio Biosolutions receives CE Certification for next gen wound-care product MaxioCel
05 February 2021 | News
This next-generation advanced wound-care dressing, MaxioCel is based on Bioactive Microfiber Gelling technology that accelerates healing through quicker granulation
Axio Biosolutions, based in Bengaluru, has announced that it has received CE Certification from Europe for its next generation advanced wound-care product range, MaxioCel. The regulatory approval paves the path for Axio to tap into a fast growing $14 billion advanced wound-care market, globally. 
This next-generation advanced wound-care dressing, MaxioCel is based on Bioactive Microfiber Gelling technology that accelerates healing through quicker granulation. It also provides comfort and has shown faster healing on chronic wounds, such as pressure ulcers, diabetic foot ulcers, venous leg ulcers, cav ....

Kokilaben Dhirubhai Ambani , Leo Mavely , Axio Biosolutions , Raghuram Sekhar , Bioactive Microfiber Gelling , Consultant Vascular , Endovascular Surgeon , Kokilaben Dhirubhai Ambani Hospital , Ce Certification , Wound Care , கோகிலபேண் திருபைய் அம்பானி , ரகுராம் சேகர் , ஆலோசகர் வாஸ்குலர் , எண்டோவாஸ்குலர் அறுவை சிகிச்சை நிபுணர் , கோகிலபேண் திருபைய் அம்பானி மருத்துவமனை , ஸ் சிஇஆர்டிஐஎஃப்ஐசிஏடிஐஓஎன் , காயம் பராமரிப்பு ,